SCHEMBL13487652

SCHEMBL13487652

CC1(C)c2ccccc2-c2cc(-c3c4ccccc4c(-c4ccc(F)cc4)c4ccc(-c5ccc6ccccc6c5)cc34)ccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.36
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35
PGR P06401 1/20 0.33
ACHE P22303 1/20 0.33
CYP1A2 P05177 4/20 0.33
CYP2A6 P11509 1/20 0.33
KDM4E B2RXH2 1/20 0.32
CYP3A4 P08684 1/20 0.32
HPGD P15428 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
LPL P06858 1/20 0.32
LIPG Q9Y5X9 1/20 0.32
CYP1A1 P04798 2/20 0.32
CYP1B1 Q16678 2/20 0.32
PTGER3 P43115 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13488045 0.93 PDK2 (0.41) PDK2PIK3CDPIK3CAMTORPGR
SCHEMBL13487740 0.90 PDK2 (0.43) PDK2PGRACHE
SCHEMBL13487505 0.90 PDK2 (0.40) PDK2PGRACHECYP1A2KDM4E
SCHEMBL13487590 0.89 PDK2 (0.33) PDK2PGRACHECYP1A2KDM4E
SCHEMBL13487733 0.88 ESR1 (0.35) PDK2LPLLIPGPTGER3AKR1C3
SCHEMBL13487656 0.88 MAPK9 (0.37) PDK2CYP1A2CYP3A4CYP2C19LPL
SCHEMBL13487694 0.88 PDK2 (0.40) PDK2PGRACHECYP1A2CYP2A6
SCHEMBL13487270 0.88 PIK3CD (0.34) PDK2PIK3CDPIK3CAMTORPGR
SCHEMBL13487693 0.86 PDK2 (0.38) PDK2PGRPTGER3
SCHEMBL13487714 0.86 AKR1C3 (0.31) LPLLIPGPTGER3GPR84AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 PDK2 1456/4885PIK3CD 2155/4885PIK3CA 3662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.